Dimitrios Karantanis
Overview
Explore the profile of Dimitrios Karantanis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
227
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vassilakopoulos T, Piperidou A, Mellios Z, Verigou E, Katodritou E, Kalpadakis C, et al.
Hemasphere
. 2023 Nov;
7(11):e965.
PMID: 38027423
No abstract available.
2.
Kalkanis A, Palaiodimos L, Klinaki I, Karantanis D, Kalkanis D
Nucl Med Mol Imaging
. 2017 Sep;
51(3):277-280.
PMID: 28878858
A 63-year-old male with a recently diagnosed right lung lesion was referred for staging. F-FDG PET/CT scan revealed a hypodense, cystic-like mass in the right upper lung lobe, which demonstrated...
3.
Karantanis D, Kalkanis D, Czernin J, Herrmann K, Pomykala K, Bogsrud T, et al.
J Nucl Med
. 2014 Dec;
55(12):1925-9.
PMID: 25453041
Unlabelled: Because only pathologic examination can confirm the presence or absence of malignant disease in cancer patients, a certain rate of misinterpretation in any kind of imaging study is inevitable....
4.
Dibble E, Karantanis D, Mercier G, Peller P, Kachnic L, Subramaniam R
AJR Am J Roentgenol
. 2012 Oct;
199(5):952-67.
PMID: 23096166
Objective: Pancreatic cancer continues to have a poor prognosis despite impressive improvements in the outcomes of many other types of cancer, often because most pancreatic neoplasms are found to be...
5.
Karantanis D, Kalkanis D, Allen-Auerbach M, Bogsrud T, Subramaniam R, Danielson A, et al.
J Nucl Med
. 2012 Aug;
53(10):1499-505.
PMID: 22917886
Unlabelled: Oncologic (18)F-FDG PET/CT is rapidly gaining acceptance in clinical practice. However, the referring physician's attitude toward the usefulness of this diagnostic modality is unknown. This survey was undertaken to...
6.
Karantanis D, Allen-Auerbach M, Czernin J
Clin Nucl Med
. 2012 Apr;
37(5):e98-9.
PMID: 22475925
Squamous papilloma is one of the most common benign neoplasms of the oral cavity and oropharynx. The (18)F-FDG PET/CT metabolic phenotype of this entity has not been described. We document...
7.
Karantanis D, Allen-Auerbach M, Czernin J
Hell J Nucl Med
. 2012 Mar;
15(1):2-8.
PMID: 22413105
Positron emission tomography (PET)/computed tomography (CT)-subsequently referred to as PET/CT is emerging as a critically important diagnostic tool in oncology. There has been a substantial increase in the utilization of...
8.
Karantanis D, Allen-Auerbach M, Czernin J
Clin Nucl Med
. 2011 Dec;
37(1):49-53.
PMID: 22157028
Purpose: Knowing the glycolytic phenotype of cancers is important for the appropriate use of F-18 FDG PET/CT imaging. This study was performed to determine the influence of tumor grade and...
9.
Bogsrud T, Hay I, Karantanis D, Nathan M, Mullan B, Wiseman G, et al.
Nucl Med Commun
. 2011 Feb;
32(4):245-51.
PMID: 21278616
Objective: To explore the prognostic value of F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) in radioiodine-negative patients with differentiated follicular cell-derived thyroid carcinoma with circulating antithyroglobulin autoantibodies (TgAb). Methods: We retrospectively reviewed...
10.
Bogsrud T, Karantanis D, Nathan M, Mullan B, Wiseman G, Kasperbauer J, et al.
Mol Imaging Biol
. 2009 Dec;
12(5):547-53.
PMID: 19949985
Purpose: To explore the prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose (FDG) positron emission tomography (PET) in patients with suspected residual or recurrent medullary thyroid carcinoma (MTC). Procedures: This retrospective study included all...